Quantcast
Channel: Biotechnology Forums - All Forums
Viewing all 2695 articles
Browse latest View live

Antibiotic-resistance genes in viruses in fossilised 14th century human faecal sample

$
0
0
A discovery of viruses harbouring antibiotic-resistance genes in fossilised faecal samples dating from the 14th century could have implications not only for microbiologists but also for archaeologists, historians and anthropologists. The discovery was made by French researchers who studied samples from latrines from the period uncovered during an urban renewal project in the city of Namur in Belgium. The study is published ahead of print in the journal Applied and Environmental Microbiology.

The viruses found in the coprolites (fossilised faecal samples) are phages, i.e. viruses that infect bacteria rather than eukaryotes. These phages were examined by a mixture of “electron microscopy, high-throughput sequencing and suicide PCR approaches” according to corresponding author Christelle Desnues of Aix Marseille Université. The presence of the phages in the coprolites indicates that they would also have been present in the gastrointestinal tract. Many of the phage sequences identified were related to phages known in modern times to infect bacteria commonly identified in stools, including both harmless, helpful and pathogenic bacteria.

The findings revealed that the phages carried genes for antibiotic resistance, long before antibiotics were used therapeutically. The phages also carried toxin-resistance genes. Both antibiotics and toxins are commonly found in nature. The authors believe that these resistance genes would have protected gut bacteria. In this regard, they would have been essential in maintaining gut metabolism and health as the helpful bacteria inhabiting the gut and other body areas are important in human health. The results are consistent with other studies, for example of the human oral microbiome in skeletons of 1000 years old in which antibiotic-resistance genes were also found.

The phages in the coprolites differed taxonomically those within modern human faecal samples. However, Dr Desnues says that functionally their role has conserved. This adds weight to the hypothesis that the viral community in the human gastrointestinal tract play a fundamental role which has been conserved over centuries, despite dramatic changes in human diet and living conditions. The researchers are currently expanding their studies to fungi and parasites in the coprolites.

Sources:

Press release from American Society for Microbiology; available at http://www.eurekalert.org/pub_releases/2...022714.php [Accessed 28 February 2014].

APPELT, S., FANCELLO, L., LE BAILLY, M., RAOULT, D., DRANCOURT, M. and DESNUES, C., 2014. Viruses in a 14th-century coprolite. Appl. Environ. Microbiol. published ahead of print 7 February 2014 doi:10.1128/AEM.03242-13

WARINNER, C., RODRIGUES, J.F.M., VYAS, C., TRACHSEL, R., SHVED, N., GROSSMANN, J., RADINI, A., HANCOCK, Y., TITO, R.Y., FIDDYMENT, S., SPELLER, M., HENDY, J., CHARLTON, S., LUDER, H.U., SALAZAR-GARCÍA, D.C., EPPLER, E., SEILER, R., HANSEN, L.H., SAMANIEGO CASTRUITA, J.A., BARKOW-OESTERREICHER, S., TEOH, K.Y., KELSTRUP, C.D., OLSEN, J.V., NANNI, P., KAWAI, T., WILLERSLEV, E., VON MERING, C., LEWIS JR, C.M., COLLINS, M.J., GILBERT, M.T.P., RÜHLI, F. and CAPPELLINI, E., 2014. Pathogens and host immunity in the ancient human oral cavity. Nature Genetics 2014; doi:10.1038/ng.2906 (Advance online publication).

Post-Doc Fellowship for Researchers from India, East Europe & South America

$
0
0
We are offerring Post-Doc Fellowship in Food Biotechnology with research on Development & Characterization of Food Flavors. The candidates could be PhDs in Food Science & Technology, Biotechnology & related disciplines. The candidates who have recently completed their PhD and possess sound knowledge on Chromatographic techniques (HPLC, GC, MS) would be preferable.

Pl submit your curriculum alongwith references, publications list etc direct to my email:

narendra.narain@gmail.com

Contact: Prof. Dr. Narendra Narain

Genetic Engineering

$
0
0
hey....i am a S.Y.B.Sc.Biotechnology student from Mumbai, India...i want to persue my career in Genetic Engineering...i need help in how to go about it???...which colleges are best??...how to apply abroad???...wat are the Job/Career oportunities??...as well as are there any Summer internship programs???...is any additional course required to support my career??...plzzzz reply ASAP

BEST JOB PORTAL FOR BOTH CANDIDATES AND COMPANIES ON SAME PLATFORM

$
0
0
Hello

Placement 2 Placement is an India based company that is engaged in providing excellent placement solutions to public and recruitment facilities to companies and bring both candidates and vacancies on the same platform according to their requirements and skills as they may perform with their level best and achieve heights together.
For More detail Contact us Today
http://www.placement2placement.com/

Thanks
Jenny Khan
Senior HR

Small nuclear RNAs: new tool for cancer prediction?

$
0
0
Small non-coding RNAs, long dismissed as 'transcriptional noise' due to their apparently random distribution and lack of any discernible link to known functions, may actually be predictive of individuals who may develop breast cancer. That’s according to a study published today in EMBO Reports from researchers who contribute to The Cancer Genome Atlas project. This project is one of the largest available resources for small non-coding RNAs. The researchers are from the BC Cancer Agency, Simon Fraser University and the University of British Columbia, all in Vancouver, and Harvard Medical School.

Small non-coding RNAs, as the name suggests, do not give rise to protein products but may have other cellular functions. They are often found near transcriptional start sites but their function is often unclear. In the current study, the researchers were interested in distinguishing between the many different small non-coding RNAs that are found near the transcriptional start sites of genes in healthy individuals versus patients with breast invasive carcinoma. They used a computational technique to filter away some of the ‘transcriptional noise’ and arrived at a subset of small non-coding RNAs which were rich in CpG islands, i.e. in cytosine and guanine residues. They were also negatively correlated with methylation status. These small non-coding RNAs were mapped to specific DNA sequence locations and the researchers then looked to see if there was any relationship between strongly-expressed non-coding RNAs and the disease status of the patients from whom the tissue samples had been taken. Importantly, they used the information generated to try to predict the presence of disease in other tissue samples from breast cancer patients and found that they could efficiently predict the correct disease status for these samples. Thus these RNAs could potentially be used to classify cancer patients according to different survival outcomes.

Dr Steven Jones, the senior author on the study concluded that: "This is the first time that small non-coding RNAs near the transcription start site of genes have been associated with disease….Further work is required but based on our data we believe there is considerable diagnostic potential for these small non-coding RNAs as a predictive tool for cancer. In addition, they may help us understand better the mechanisms underlying oncogenesis at the epigenetic level and lead to potential new drugs employing small non-coding RNAs."

Sources

ZOVOILIS, A., MUNGALL, A.J., MOORE, R., VARHOL, R., CHU, A., WONG, T., MARRA, M. and JONES, S.J.M., 2014. The expression level of small non‐coding RNAs derived from the first exon of protein‐coding genes is predictive of cancer status. EMBO Reports, 2014. DOI: 10.1002/embr.201337950 |Published 17.02.2014

http://www.eurekalert.org/pub_releases/2...021314.php [Accessed 17 February 2014].

Immunoproteasome inhibitor treats multiple sclerosis

$
0
0
For over a decade, the development of potent protease inhibitors, like the breakthrough drug Bortezomib, have been an important therapuetic strategy of cancer drug development. Now researchers are extending the use of protease inhibitors for the treatment of the autoimmune disease, multiple sclerosis.<br >
<br>
<a href="http://www.genscript.com/reference_peer-reviewed_literature_9407.html?src=backlink"> Read the publication </a> <br>
<br>


In a study published in EMBO Molecular Medicine, scientists used an inhibitor called ONX 0914 to selectively inhibit a special kind of proteasome, called an immunoproteasome. Immunoproteasome synthesis is induced by cellular stimulation with IFN-γ and tumor necrosis factor, which causes subunits of conventional proteasomes to have altered structure.<br><br>
The unique structure of the immunoproteasome allows for unique processsing of MHC I peptides which result in stimulation of T cell differentiation and progression of autoimmune diseases.

Milk does the heart good: Milk-derived peptides exhibit antihypertensive effect

$
0
0
Bioactive milk peptides have potential in the treatment of a number of ailments including cancer and diabetes. In a recent publication, orally administered milk-derived peptides were shown to survive the gastrointestinal tract and exhibit anti-hypertension effects similar to a well-known anti-hypertension drug, captrophil.


Peptides derived from milk can serve as angiotensin I converting enzyme inhibitors (ACE inhibitors). ACE normally hydrolyzes the vasoconstrictor, angiotensin I, to angiotensin II, and hydrolyzes the vasodilator, bradykinin, to an inactive peptide that upregulates blood pressure. In the study, a lactose fermenting yeast, Kluyvermyces marxianus, was used to release the bioactive peptides from bovine lactoferrin (a component of whey milk).

A total of 6 milk peptides with antihypertensive effects were identified. These peptides were custom synthesized by GenScript and orally administered to mice models. The antihypertensive effect of select bioactive milk peptides were found to be as effective as captrophil.

Crystal structures are still reveal novel features of protein folding & substrate bin

$
0
0
In a recent paper published in Nature Chemical Biology, new crystal structures provide insights into the evolution and activity of the AdoMet radical enzyme family that plays a critical role in purine biosynthesis. By crystallizing QueE in complex with its catalyst and substrates, they discovered that QueE contains a modified core fold unlike any other family member. A close look at the active site before and after substrate binding revealed even more secrets -- Read More.



These crystal structures were obtained using a codon-optimized QueE gene that was synthesized by GenScript.
GenScript has the expertise to rapidly synthesize codon-optimized gene constructs for the efficient expression of proteins you need for crystallography.

Don't let molecular biology slow down your structural studies!

Biologics Data Management System

$
0
0
Hyderabad, India and Indianapolis, IN, USA, March 11, 2014: Ocimum Biosolutions announces release of its new software product, Sciantis™, a lab process and data management platform for biologics labs. Sciantis™ helps Labs to manage Biologics development process, automate data capturing and support lab Analytics needs.

Mr. Subash Lingareddy, CFO, President of Ocimum Biosolutions, said, “Sciantis™ is our new software offering to serve Biologics companies in improving their development process and data management. This software also serves the regulatory needs of data capturing and management”.

Mr. Sridhar Reddy, Senior Vice-President, Bio-IT said, “Sciantis™ is a new feather in our cap; we have designed Sciantis™ based on our 12+ years of experience in handling Lab process automation, data Management and Analytics”.

About Sciantis™

Sciantis™ offers rich set of features including Biologics Registration, Clone management, Vector design and Management, Cell line Banking, Location management, Instrument management, Lab consumables management, High-throughput Plate Management, Scheduling Reactors and Sampling, Analytical Method development for upstream, in-process and downstream processes , Analytical Results tracking, Report Engine, notifications, Alerts and etc. Sciantis™ is 21 CFR Part11 compliant for electronic records with full audit trails and role based access. It is fully web based system works well in all popular browsers, support smart devices.

Improved, traceable membrane protein production in E.coli through tandem fusions and

$
0
0
Membrane protein expression remains a bottleneck in its characterization and structure determination. In a recent study, scientists created a robust strategy to increase the probability of membrane protein overexpression by generating a traceable fusion system at the C-terminus of their target protein, showing that manipulation of transcriptional silencing improved membrane protein overexpression.

For years, Genscript scientists have produced challenging membrane proteins in bacterial insect, mammalian and yeast expression systems. With its world-class expertise and PhD-level technical support, GenScript will be a reliable partner for all your protein production needs.

With its world-class expertise and PhD-level technical support, GenScript will be a reliable partner for all your protein production needs.

Antibody against clotting factor prevents thrombosis without increasing bleeding risk

$
0
0
A recent publication in Science Translational Medicine describes the use of a humanized monoclonal antibody against activated

FXIIa, identified using phage display, to prevent the formation of blood clots without increasing the risk of bleeding. Preventing

thrombus formation while using a bypass system often leads to unwanted bleeding, sometimes in the brain, making this breakthrough

treatment an attractive alternative to heparin.

GenScript offers Custom mAb production services to develop your specific antibody and Antibody Library and Phage Display services

which can build a library with up to 1010 individual clones.

3 Critical Proteins for Maintaining Stem Cells in Culture

$
0
0
STAP (Stimulus-triggered acquisition of pluripotency) cells have made recent science headlines with reports that mouse somatic cells can be reprogrammed into pluripotent cells simply by being subjected to external stress. Unlike, IPSCs (induced pluripotent stem cells) which require successful transfection with a specific set of pluripotent transcription factors, STAPs are generated without any type of exogenous genetic transfer or manipulation. While the article has raised controversy, it has also brought attention to the importance of stem cell research and the great impact a new method for generating stem cells could have on treating several types of disease. This is why it is critical to use the correct high-quality proteins when maintaining different types of stem cells in culture.


Mouse Embryonic Stem Cells, Induced Pluripotent Stem Cells, and STAP Research

1. Leukemia Inhibitory Factor (LIF) - a critical component to maintain stem cell self-renewal through its activation of the STAT3 pathway. Absence of LIF without subsequent genetic manipulation results in stem cell differentiation. LIF is used in all 3 types of Mouse stem cell culture (Embryonic, Induced Pluripotent and newly defined Stimulus-triggered acquisition of pluripotency).

Human Embryonic Stem Cells and Induced Pluripotent Stem Cells

2. Fibroblast Growth Factor-basic (FGF-basic) - This growth factor is the human equivalent to LIF. High concentrations of FGF-basic are critical for maintaining self-renewal of both human embryonic and human induced pluripotent stem cells in culture.

3. Noggin - The addition of this glycoprotein with FGF-basic is essential for sustaining pluripotent stem cells in an undifferentiated state. Noggin binds to and inhibits Bone Morphogenic Protein-4 (BMP-4) thereby blocking its ability to promote stem cell differentiation. Supplement FGF-basic with Noggin to maintain both human embryonic and human induced pluripotent stem cells in culture.

(Yesterday 03:45 PM)Genscriptlorraine Wrote:  STAP (Stimulus-triggered acquisition of pluripotency) cells have made recent science headlines with reports that mouse somatic cells can be reprogrammed into pluripotent cells simply by being subjected to external stress. Unlike, IPSCs (induced pluripotent stem cells) which require successful transfection with a specific set of pluripotent transcription factors, STAPs are generated without any type of exogenous genetic transfer or manipulation. While the article has raised controversy, it has also brought attention to the importance of stem cell research and the great impact a new method for generating stem cells could have on treating several types of disease. This is why it is critical to use the correct high-quality proteins when maintaining different types of stem cells in culture.


Mouse Embryonic Stem Cells, Induced Pluripotent Stem Cells, and STAP Research

1. Leukemia Inhibitory Factor (LIF) - a critical component to maintain stem cell self-renewal through its activation of the STAT3 pathway. Absence of LIF without subsequent genetic manipulation results in stem cell differentiation. LIF is used in all 3 types of Mouse stem cell culture (Embryonic, Induced Pluripotent and newly defined Stimulus-triggered acquisition of pluripotency).

Human Embryonic Stem Cells and Induced Pluripotent Stem Cells

2. Fibroblast Growth Factor-basic (FGF-basic) - This growth factor is the human equivalent to LIF. High concentrations of FGF-basic are critical for maintaining self-renewal of both human embryonic and human induced pluripotent stem cells in culture.

3. Noggin - The addition of this glycoprotein with FGF-basic is essential for sustaining pluripotent stem cells in an undifferentiated state. Noggin binds to and inhibits Bone Morphogenic Protein-4 (BMP-4) thereby blocking its ability to promote stem cell differentiation. Supplement FGF-basic with Noggin to maintain both human embryonic and human induced pluripotent stem cells in culture.

Leukemia Inhibitory Factor (LIF):http://www.genscript.com/protein-list/code--z03077/1.html?src=backlink

heat-transfer fluid - alternatives ?

$
0
0
Hello German collegs,
is there an alternativ product available in the market for:
“heat-transfer fluid”
for Osmometer/Cryoscope from Advanced Instruments Inc. USA ?
Greetings from Morocco,
Fred

Rare codons in the N-terminal region enhance protein expression

$
0
0
Although the Central Dogma was first stated by Francis Crick over a half-century ago, we're still learning exactly how transcription and translation are orchestrated in cells. A recent Science paper reports that the presence of AT-rich rare codons in the N-terminal region enhances protein expression by reducing RNA secondary structure in bacteria.

You can harness this finding to increase your protein expression to a new level. By taking advantage of the degeneracy of the genetic code, you can alter your nucleotide sequence to favor efficient protein expression while preserving the amino acid sequence you need – a technique called codon optimization.

codon optimization.http://www.genscript.com/codon_opt.html?src=backlink

The ‘love hormone’ oxytocin and protection from addiction

$
0
0
Poor development of so-called ‘love hormone’ oxytocin system could play a major role in susceptibility to addiction. This is the theme of a special edition of the international journal Pharmacology, Biochemistry and Behavior, guest edited by Dr Femke Buisman-Pijlman from the University of Adelaide's School of Medical Sciences, an expert in both addiction and family studies.

Oxytocin is both a hormone released by the pituitary gland and a neurotransmitter. It is termed the ‘love hormone’ as its levels go up when we hug or kiss a loved one and has a major role in pair bonding. Oxytocin levels are stimulated during sex, birth and breast feeding. It causes increased womb contraction during labour and stimulates ejection of milk into the breast ducts. While newborns do have oxytocin, Dr Buisman-Pijlman points out that: “our oxytocin systems aren't fully developed when we're born – they don't finish developing until the age of three, which means our systems are potentially subject to a range of influences both external and internal."

Influences on the oxytocin system would be both genetic and environmental. While we have no control over our genes, the environmental factors impacting on the oxytocin system are significant. Reductions in the development of oxytocin levels can be caused by factors ranging from a difficult birth or abuse in childhood to infections. Interestingly, research suggests that the seeds of risk for drug addiction are already sown by the age of four, just after the time that our oxytocin system has finished developing. The factors linking the oxytocin system and addiction are summarised in the accompanying figure (University of Adelaide).

The special issue of Pharmacology, Biochemistry and Behavior examines the impact of poor oxytocin system development and resilience against addiction from a number of angles. In a historical overview, the idea is introduced that oxytocin reduces the type of long-term neural adaptation that underlies drug addiction. Further papers explore the link between oxytocin development and early life, including gestational drug exposure and early childhood experiences. Interactions between dopamine and oxytocin are examined, including the influence of forming early social attachments on subsequent coping mechanisms in terms of stress and addiction. Other papers examine the effect of oxytocin on drug-induced mood, including the tendency of a well-developed oxytocin system to reduce the feeling of pleasure associated with drugs.

In all, these studies provide an important insight into factors linking reduced oxytocin and addiction. Dr Buisman-Pijlman concludes: "Understanding what occurs with the oxytocin system during the first few years of life could help us to unravel this aspect of addictive behaviour and use that knowledge for treatment and prevention."

Sources:

THE ROLE OF OXYTOCIN IN POSITIVE AFFECT AND DRUG-RELATED REWARD. Pharmacology, Biochemistry and Behavior (special edition, edited by Femke T.A. Buisman-Pijlman, Jillian H. Broadbear and Zoltán Sarnyai), Volume 119, Pages 1-88 (April 2014), available on http://www.sciencedirect.com/science/jou...913057/119

Press release: University of Adelaide

.jpg  70475_web.jpg (Size: 17.21 KB / Downloads: 3)

Algae: truly a ‘green’ organism for biotechnological processes?

$
0
0
We are now in an era where development of sustainable energy sources and more environmentally friendly biochemical production are priorities. In this context, algae are emerging as potentially useful organisms in applications including production of biochemical and biofuel and for trapping carbon dioxide emissions generated by industry. Cultivation of algae is expensive when compared to, for example, wood and agricultural biomass and is particularly challenging in countries with a cool climate and long hours of darkness in winter. Mindful of these issues, the ALGIDA project has been looking into algae cultivation in Finland. The project is coordinated by VTT Technical Research Centre of Finland. Their results are encouraging to the view that profitable algae cultivation is possible in countries with cold, dark winters.

Algae are a potentially multi-use biotechnological source. The utility of its components extend beyond biofuels to, for example, pigments and cosmetics and nutritional supplements such as omega-3. Biomass from algae can also be used as biofertiliser. Clearly, they are a resource whose cultivation is worth pursuing. The aviation industry is a prime example of a potential customer for algae-based biofuels. Their use in biofuels depends on establishment of growing conditions whereby they produce a high level of lipids and their economic sustainability requires use of all components of the algae biomass. The ALGIDA project suggests various ways round the issues of lack of heat and light in Finland. Project manager Mona Arnold from VTT suggests that: “The most sensible thing to do in Finland is to integrate cultivation into industrial processes with spill heat and focus development on the production of biofuels and biochemical compounds, and on nutrient removal from effluents. Algae can also be used to recover nutrients, organic impurities and heavy metals from waste and waste water.”

The research of the ALGIDA project examined the plausibility of algae cultivation in Finnish waste waters and ways of improving conditions. The project findings suggested that the algae needed heat to thrive but could manage in the absence of light. In terms of a carbon dioxide source, the project findings suggested use of carbon dioxide in the air during the summer when there was light and from waste sugar in winter. To create warmth, they suggest linking algae cultivation to industrial processes which create residual heat in order to warm up the algae cultivation ponds or reactors.

Currently, VTT are collaborating with the oil and gas company ONGC in India and with CLEEN Ltd. (Cluster for Clean Energy and Environment in Finland). They are planning a pilot project to show the capacity of algae to bind carbon dioxide emissions from a natural gas refinery. This has a three-fold purpose of showing potential of algae in a CO2 capture, the best applications for algal biomass and capacity for algae growth in industrial waste water.

These findings will have relevance for use of algae in other countries where heat and light may an issue and should help advance knowledge on how humble algae may one day be used in activities such as aviation.

Sources:

Research report online: http://www.vtt.fi/inf/pdf/technology/2013/T147.pdf

Press release: VTT Technical Research Centre of Finland

Soon cancer and cardiovascular disease detection could be as simple as taking a pregn

$
0
0
In a recent study, published in PNAS, researchers developed an ingenious point-of-care diagnostic method using synthetic peptide biomarkers and immunoassays. The method was capable of detecting and quantifying colorectal cancer and thrombosis biomarkers directly from unpurified urine.



With additional development, the test is proposed to be applicable for detection of a host of noncommunicable diseases, without the requirement for expensive equipment or medically trained personnel. The cost of manufacturing a simple lateral flow assay device was estimated to be less than $2.60 per test.

(Today 12:28 PM)Genscriptlorraine Wrote:  In a recent study, published in PNAS, researchers developed an ingenious point-of-care diagnostic method using synthetic peptide biomarkers and immunoassays. The method was capable of detecting and quantifying colorectal cancer and thrombosis biomarkers directly from unpurified urine.



With additional development, the test is proposed to be applicable for detection of a host of noncommunicable diseases, without the requirement for expensive equipment or medically trained personnel. The cost of manufacturing a simple lateral flow assay device was estimated to be less than $2.60 per test.

Genscript peptide news

Protein C Tag Antibody (HPC4)

$
0
0
Protein C (HPC4) tag encodes residues 6 through 17 of the protein C heavy chain. Compared with the His tag, Protein C tag can capture higher purity proteins from

Escherichia coli, yeast, Drosophila, and HeLa extracts.
GenScript has developed highly specific and sensitive Protein C tag antibodies for detection and analysis of fusion proteins with Protein C tag.

(02-24-2014 06:34 PM)Genscriptlorraine Wrote:  Protein C (HPC4) tag encodes residues 6 through 17 of the protein C heavy chain. Compared with the His tag, Protein C tag can capture higher purity proteins from

Escherichia coli, yeast, Drosophila, and HeLa extracts.
GenScript has developed highly specific and sensitive Protein C tag antibodies for detection and analysis of fusion proteins with Protein C tag.

GenScript has developed highly specific and sensitive Protein C tag antibodies for detection and analysis of fusion proteins with Protein C tag.
http://www.genscript.com/antibody/A01774...c=backlink

Query regarding Lawn Culture that I performed.

$
0
0
MY question is regarding the lawn culture results. During my last lab class, I performed the Kirby-Bauer Disk Diffusion Susceptibility Test. To attain results in this experiment I needed to perform Lawn culture. However, after I performed the lawn culture and placed the antibiotic disks, after incubation no growth was observed.

I would like to know, why no growth was observed?

Thank you. Big Grin Big Grin

Question regarding final year thesis/project work.

$
0
0
I'm currently in my 8th semester. I realize that I don't have much time as I'm going to graduate soon. I'm actually wondering on what to work on my thesis for my final year. If you could please advise me, it would be of great help. I pretty much clueless here. My field of interests are medical and industrial biotechnology.

Thank you. Big Grin Big Grin
Viewing all 2695 articles
Browse latest View live




Latest Images